Shenzhen Genocury Biotechnology Co., Ltd.
PrivateLast Round
Series D
Nov 1, 2025
Est. Valuation
$610M
Total Funding Raised
$276.59M
Company Overview
Shenzhen Genocury Biotechnology Co., Ltd. is a biotechnology company that focuses on the research and development of gene and cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Genocury Biotechnology Co., Ltd. Comparables
Compare Shenzhen Genocury Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Umoja Biopharma | 83% | |
| CREATE Medicines | 79% | |
| Alaya.bio | 78% |
Shenzhen Genocury Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 1, 2025 | ||||
| Series A | Jun 18, 2024 | ||||
| Angel Extension | May 15, 2024 | ||||
| Early Funding | Apr 21, 2023 | ||||
| Angel | Jan 31, 2023 | ||||
Series C | Jul 22, 2021 |
Shenzhen Genocury Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Weiting Capital | Series C |
| Beijing Chang Development | Series D |
| Chuanghehui Capital | Series C |
| Highlight Capital | Series B Extension |
| Desun Capital | Series B |
| Baidu Ventures | Series C |
| Tianjin Venture Capital Management Co., Ltd. | Angel Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2024
Tianjin Venture Capital Management led the round.
- Apr 21, 2023
Honghui Capital participated in the early funding round.
Shenzhen Genocury Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shenzhen Genocury Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen Genocury Biotechnology Co., Ltd. a public or private company?
Shenzhen Genocury Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shenzhen Genocury Biotechnology Co., Ltd.?
Shenzhen Genocury Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Shenzhen Genocury Biotechnology Co., Ltd. worth (valuation)?
Shenzhen Genocury Biotechnology Co., Ltd.'s valuation is estimated at $610.0M based on funding round data.
Can I buy Shenzhen Genocury Biotechnology Co., Ltd. stock?
Shenzhen Genocury Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shenzhen Genocury Biotechnology Co., Ltd.'s last funding round?
Shenzhen Genocury Biotechnology Co., Ltd.'s most recent funding round was Series D on November 1, 2025.
Who are the main investors in Shenzhen Genocury Biotechnology Co., Ltd.?
Key investors in Shenzhen Genocury Biotechnology Co., Ltd. include Huagai Capital, CoStone Capital, CCB International (Holdings) Limited.
Will Shenzhen Genocury Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen Genocury Biotechnology Co., Ltd..
How can I track Shenzhen Genocury Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shenzhen Genocury Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.